Regular Article
Transcription of the SERCA2 Gene is Decreased in Pressure-overloaded Hearts: A Study Using In Vivo Direct Gene Transfer into Living Myocardium

https://doi.org/10.1006/jmcc.1999.1045Get rights and content

Abstract

T. Takizawa, M. Arai, A. Yoguchi, K. Tomaru, M. Kurabayashi and R. Nagai. Transcription of the SERCA2 Gene is Decreased in Pressure-overloaded Hearts: A Study Using In Vivo Direct Gene Transfer into Living Myocardium.Journal of Molecular and Cellular Cardiology (1999) 31, 2167–2174. The sarcoplasmic reticulum Ca2+-ATPase (SERCA2) controls the myocardial relaxation process. Under pressure-overload, the expression of its mRNA decreases, thus controlling cardiac function to conform to the load. However, it is not known whether this decreased expression is caused by a decrease in the transcription of the SERCA2 gene. The object of this study was to determine the transcription control mechanism of the SERCA2 gene under pressure-overload in vivo, and to identify the pressure-overload-sensitive regions of the SERCA2 gene. Ten micrograms of a plasmid, containing the 5′ upstream (−1810 bp to +350 bp) region of the SERCA2 gene and a luciferase reporter gene, were introduced into adult rat myocardium by in vivo direct gene transfer, and the luciferase activity was measured 5 days later. The transcriptional activity under pressure-overload decreased to 27±17% of the control. Based on this result, we concluded that the decreased mRNA expression of SERCA2 in pressure-overload cardiac hypertrophy is due to decreased gene transcription. In addition, various deletion fragments of the SERCA2 promoter region were produced, and tested for luciferase production under pressure-overload. Our data suggest that a transcription activation site is present between −685 and −284 bp, and two transcription inhibition sites are present between −1810 to −1110 bp and −284 to −72 bp. These may be the pressure-sensitive regions of the SERCA2 gene of in vivo hypertrophied myocardium under pressure-overload.

References (22)

  • R Harsdorf et al.

    Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure-overload

    J Clin Invest

    (1997)
  • Cited by (26)

    • Mechanical stress-dependent transcriptional regulation of sarcolipin gene in the rodent atrium

      2005, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      We found that the expression level of SERCA2a mRNA was also decreased in the atria by mechanical stress. Two previous studies have demonstrated that the transcription of SERCA2a in the atria is decreased by mechanical stress [4,5], which is consistent with data form many studies investigating the change in SERCA2a transcripts in the pressure or volume-overloaded ventricles [2,18–20]. Although we did not assess the functional consequences of reduction in the SERCA2a transcripts by mechanical stress, a considerable number of studies have demonstrated that the reduction in SERCA2a mRNA results in a subsequent decrease in SERCA2a proteins and Ca2+ uptake in ventricles with mechanical stress [21–23].

    • Phenotypes of SERCA and PMCA knockout mice

      2004, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      The major objectives were to determine whether loss of one copy of the SERCA2 gene would lead to impaired cardiac performance or heart disease and whether compensatory mechanisms were activated in the heart. This is of interest because many studies have shown that SERCA2a mRNA, protein, and activity are reduced in diseased cardiac muscle and it has been suggested that these reductions may contribute to the pathogenic process [38–40]. Given the role of SERCA2a as the cardiac SR Ca2+ pump and SERCA2b as the major ER Ca2+ pump in all tissues, it seemed unlikely that null mutants would survive to birth.

    View all citing articles on Scopus
    f1

    Please address all correspondence to: Masashi Arai, Second Department of Internal Medicine, Gunma University School of Medicine, 3-39-15 Showa-machi, Maebashi, Gunma, 371-8511, Japan.

    View full text